The mainland Chinese biotech firm generated strong demand, with the retail tranche of the offering on the Hong Kong bourse 200-times oversubscribed.
APAC Financial Markets • #3SBio, #Equities, #HongKong, #IPO #Equities, #Issuance/Pipeline
The mainland Chinese biotech firm generated strong demand, with the retail tranche of the offering on the Hong Kong bourse 200-times oversubscribed.
APAC Financial Markets • #3SBio, #Equities, #HongKong, #IPO #Equities, #Issuance/Pipeline
No comments:
Post a Comment